ProSomnus gets FDA nod for latest sleep apnea therapy device
April 13, 2026
ProSomnus announced today that it received FDA 510(k) clearance for its RPMO₂ obstructive sleep apnea (OSA) therapy device.
ProSomnus announced today that it received FDA 510(k) clearance for its RPMO₂ obstructive sleep apnea (OSA) therapy device.
Used with Beckman’s immunoassay analysers, MeMed’s BV test has been demonstrated to reduce unnecessary antibiotic use.
Learn how an isolated but collaborative bird species shows that close social contact can shape our gut microbes in surprising ways.
By using AI to analyze more than 400,000 Reddit posts, Penn researchers have identified patient-reported symptoms associated with GLP-1s, the popular weight-loss and diabetes drugs semaglutide and tirzepatide, that may not be fully captured in clinical trials or regulatory documents.
Blood- and bone marrow-based efficient growth factors extraction system demonstrates substantial equivalence and high cell viability
Electrofluidic fibers mimic how natural muscle fibers bundle, and could enable compact, silent robotic and prosthetic systems.
PITTSBURGH, April 9, 2026 /PRNewswire/ — “As a patient care coordinator, I thought there could be a better way to lift, transfer, and move a patient,” said an inventor, from Winchester, Calif., “so I invented the IN HOME MANUAL HOIST. My design offers added assistance, and it could be used in place of patient lifts or hydraulic lifts that are bulky and expensive.”
SNIPE, a newly characterized biological defense system, directly protects bacteria by chopping up invading viral DNA.
Learn how testing different environmental conditions may unlock mammals’ potential to regrow limbs and what it means for wound healing now.
Modular Medical (Nasdaq:MODD) announced today that it received FDA 510(k) clearance for its next-generation insulin patch pump.